Cook Jennifer E.

DirectorBridgeBio Pharma, Inc. (BBIO) · full profile →Form 4 · filed Jun 24, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.8M
Net Open-Market Flow
-$2.8M
Transactions
8
5 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 24, 2026Sell(S)37K$70.00$2.6M8K
Jun 24, 2026Option exercise(M)20K$8.45$169K28K
Jun 24, 2026Option exercise(M)17K$16.75$288K46K
Jun 23, 2026Sell(S)2K$68.57$151K8K
Jun 22, 2026Grant(A)4K$011K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 24, 2026Option exercise(M)20K$019K
Jun 24, 2026Option exercise(M)17K$017K
Jun 22, 2026Grant(A)5K$05K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001470831-26-000636) within minutes of acceptance. Every field above traces to the original document. Verify it directly: